Suppr超能文献

一项评估羟氯喹片在中国健康受试者体内药代动力学和生物等效性的交叉研究。

A crossover study to evaluate the pharmacokinetics and bioequivalence of hydroxychloroquine tablets in healthy Chinese subjects.

作者信息

Feng Jie, Kuang Shuang-Yu, Wan Jun-Han, Li Rong, Zhu Yi-Jie, Cai Bei-Lei, Guan Lei, Zhang Zheng

出版信息

Int J Clin Pharmacol Ther. 2024 Jun;62(6):284-292. doi: 10.5414/CP204406.

Abstract

AIMS

Hydroxychloroquine (HCQ) has a high variability and a long half-life in the human body. The purpose of this study was to evaluate the bioequivalence of a generic HCQ tablet (test preparation) versus a brand HCQ tablet (reference preparation) under fasting and fed conditions in a crossover design.

MATERIALS AND METHODS

This was an open-label, two-period randomized, single-dose, crossover study in 47 healthy Chinese subjects who were sequentially and randomly allocated either to the fed group (high-fat meal; n = 23) or the fasting group (n = 24). Participants in each group were randomized to the two arms to receive either a single 200-mg dose of the test preparation or a 200-mg dose of the reference preparation. The application of the two preparations in each patient was separated by a 28-day washout period, regarded as sufficiently long to avoid significant interference from residual drug in the body. Whole blood samples were collected over 72 hours after drug administration.

RESULTS

A total of 23 subjects completed both the fed and the fasting parts of the trial. There were no significant differences in C, AUC, and T between the test and reference preparation (p < 0.05). Food had no significant effect on C and T (p < 0.05), but AUC values were significantly reduced under fed condition compared to fasting condition (p < 0.05). The 90% confidence intervals (CIs) for the geometric mean ratios (GMRs) of C and AUC were 0.84 - 1.05 and 0.89 - 0.98 in the fed study, and 0.97 - 1.07 and 0.97 - 1.05 in the fasting study, respectively. The carryover effect due to non-zero blood concentrations resulted in higher AUC values in the second period for both test and reference formulations and had no effect on the statistical results. No serious adverse events were reported.

CONCLUSION

The investigation demonstrated that the test and reference preparations are bioequivalent and well tolerated under both fasting and fed conditions in healthy Chinese subjects.

摘要

目的

羟氯喹(HCQ)在人体内具有高度变异性和较长半衰期。本研究的目的是在交叉设计中评估一种仿制HCQ片剂(受试制剂)与一种品牌HCQ片剂(参比制剂)在禁食和进食条件下的生物等效性。

材料与方法

这是一项开放标签、两期随机、单剂量、交叉研究,纳入47名健康中国受试者,他们被依次随机分配至进食组(高脂餐;n = 23)或禁食组(n = 24)。每组参与者被随机分为两组,分别接受单次200mg剂量的受试制剂或200mg剂量的参比制剂。每位患者使用两种制剂的间隔为28天的洗脱期,该洗脱期被认为足够长,可避免体内残留药物的显著干扰。给药后72小时内采集全血样本。

结果

共有23名受试者完成了试验的进食和禁食部分。受试制剂和参比制剂之间的C、AUC和T无显著差异(p < 0.05)。食物对C和T无显著影响(p < 0.05),但进食条件下的AUC值与禁食条件相比显著降低(p < 0.05)。进食研究中C和AUC的几何平均比值(GMRs)的90%置信区间(CIs)分别为0.84 - 1.05和0.89 - 0.98,禁食研究中分别为0.97 - 1.07和0.97 - 1.05。由于非零血药浓度导致的残留效应使受试制剂和参比制剂在第二期的AUC值更高,但对统计结果无影响。未报告严重不良事件。

结论

该研究表明,受试制剂和参比制剂在健康中国受试者的禁食和进食条件下均具有生物等效性且耐受性良好。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验